키토산 및 탄산칼슘

동물 종별 용량

용량은 면허 수의 전문가를 위한 임상 참고 자료입니다. 항상 최신 라벨과 개별 환자에 대해 확인하십시오.

투여 경로

금기

• Pre-existing hypercalcaemia

이상반응

• Hypercalcaemia (due to calcium carbonate absorption)

약물 상호작용

• Calcitriol · Increased risk of hypercalcaemia when administered concurrently · major

모니터링

• Serum phosphate (at 4-6 week intervals to adjust dosage and achieve target concentrations)
• Serum total and ionized calcium (to monitor for hypercalcaemia)

과용량

Overdosage primarily increases the risk of **hypercalcaemia** due to excessive calcium carbonate intake. Signs of hypercalcaemia may include polyuria, polydipsia, vomiting, lethargy, and weakness. Treatment involves discontinuing the supplement, feeding a low-calcium diet, and providing supportive fluid therapy (e.g., 0.9% NaCl) to promote calciuresis if clinically indicated.